GlassScriptPhysician profile
Maninder Singh Bedi
NPI 1003851213
$230,219.69
in general payments reported to CMS, 2019-2025
39 companies · $4,566 in 2025
The $4,566 reported for 2025 was more than what 91% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $84K · 2020: $37K · 2021: $53K · 2022: $32K · 2023: $3,275 · 2024: $16K · 2025: $4,566.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $9,820 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $7,200 · Travel and Lodging: $4,113 · Consulting Fee: $2,375 · Education: $6.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $9,819.91 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $7,200.00 |
| Travel and Lodging | $4,112.60 |
| Consulting Fee | $2,375.00 |
| Education | $6.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $78,981.14 | 2021-2025 | Arctic Front Advance, Pulseselect, Micra |
| Medtronic Vascular, INC. | $69,237.80 | 2019-2020 | |
| Boston Scientific Corporation | $38,289.04 | 2019-2025 | Watchman Access System, Avvigo Guidance System, Watchman |
| Baylis Medical Company INC | $11,561.38 | 2019-2021 | |
| Abbott Laboratories | $10,190.39 | 2019-2025 | Aveir, Ensite Precision, Gallant |
| Biosense Webster, INC. | $9,529.35 | 2019-2025 | Carto 3 |
| Biotronik INC. | $4,765.57 | 2019-2022 | |
| Sanofi-Aventis U.S. LLC | $2,659.90 | 2019-2024 | |
| Impulse Dynamics (USA) INC. | $707.86 | 2021-2023 | Optimizer |
| Cook Incorporated | $704.12 | 2019 | |
| Kestra Medical Technology Services, INC. | $617.84 | 2022-2024 | Assure Wcd |
| Atricure, INC. | $526.23 | 2021-2024 | |
| Irhythm Technologies, INC. | $369.35 | 2019-2023 | Zio Xt Patch |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $320.94 | 2019-2025 | Lifevest |
| E.R. Squibb & Sons, L.L.C. | $305.37 | 2022-2025 | Camzyos, Eliquis |
Show all 39 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $162.59 | 2023 | Farxiga, Andexxa |
| Janssen Pharmaceuticals, INC | $127.34 | 2019-2024 | Xarelto |
| Cook Medical LLC | $123.84 | 2019 | |
| Cvrx, INC. | $120.78 | 2022-2024 | Barostim Neo System |
| Zoll Respicardia, INC. | $117.79 | 2021 | |
| Edwards Lifesciences Corporation | $98.96 | 2024 | Edwards Sapien 3 Ultra Transcatheter Heart Valve |
| Pfizer INC. | $97.27 | 2024-2025 | |
| Vektor Medical INC. | $88.52 | 2025 | Vmap |
| Boehringer Ingelheim Pharmaceuticals, INC. | $86.28 | 2023-2025 | Jardiance |
| Elutia, INC. | $54.37 | 2019 | |
| Scpharmaceuticals INC. | $51.84 | 2023-2025 | |
| Alnylam Pharmaceuticals INC. | $46.93 | 2024 | Onpattro |
| Heartflow, INC. | $42.37 | 2022 | |
| Novartis Pharmaceuticals Corporation | $38.08 | 2022-2023 | |
| Amgen INC. | $30.05 | 2021-2025 | Repatha |
| Shockwave Medical, INC | $26.68 | 2023-2024 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter, Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Esperion Therapeutics, INC. | $20.66 | 2024 | Nexletol |
| Cardiva Medical, INC. | $20.59 | 2025 | Cardiva Vascade Mvp Vvcs 6-12f |
| Novo Nordisk INC | $18.84 | 2025 | Wegovy |
| United Therapeutics Corporation | $18.72 | 2022 | |
| Merck Sharp & Dohme LLC | $18.18 | 2024 | Verquvo |
| Kiniksa Pharmaceuticals International, Plc | $16.02 | 2024 | Arcalyst |
| Bayer Healthcare Pharmaceuticals INC. | $15.71 | 2025 | |
| Amarin Pharma, INC. | $11.00 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Maninder Bedi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.